The receipt of a Notice of Allowance for a patent is a critical step in securing intellectual property rights, which can protect and enhance the value of T2 Biosystems' technological innovations. This patent, focusing on diagnostic and therapeutic methods for pathogens in whole blood, could open up new markets and applications for T2 Biosystems' products, potentially leading to increased sales and market share. The positive impact on the stock price is anticipated due to the potential for new revenue streams and competitive advantages.